# Alzheimer’s disease: FDA approves lecanemab amid cost and safety concerns

Article · Elisabeth Mahase

- Archive id: doi:10.1136/bmj.p73
- Published: 2023-01-11
- Venue: BMJ
- DOI: https://doi.org/10.1136/bmj.p73
- PMID: 36631154
- Citations: 43
- Source URL: https://doi.org/10.1136/bmj.p73
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.